Injection, Tixagevimab And Cilgavimab, For The Pre-Exposure Prophylaxis Only, For Certain Adults And Pediatric Individuals (12 Years Of Age And Older Weighing At Least 40kg) With No Known Sars-Cov-2 Exposure, Who Either Have Moderate To Severely Compromise
What Medicare pays for Q0220, what providers bill, and how the price varies across 4 states, drawn from CMS 2023 claims data.
Q0220 · the short answer
For injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromise, Medicare pays about $0.01 on average across 4 states. This is a low-payment administrative or drug code, so the billed-to-paid ratio is not a meaningful "markup."
- Medicare pays
- $0.01
- Providers bill
- $5.10
- States with data
- 4
Medicare amounts are CMS-published; markup = average submitted charge ÷ average Medicare payment.
Price Range Across States
What You Might Pay
Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.
How we estimate these prices
These estimates are based on the RAND Hospital Price Transparency Study (4th Edition, 2024), which found that commercial insurance prices average 224% of Medicare rates nationally. We apply category-specific ratios: Temporary Codes procedures average 2.24x Medicare rates. Cash/self-pay estimates blend typical cash discounts (55% of billed charges) with Medicare-based estimates (150% of allowed amounts). These are statistical estimates, not quotes. Contact your insurer or provider for actual costs.
Prices by State
| State | Medicare Payment | Billed Charge |
|---|---|---|
| California | $0.01 | $1.28 |
| Florida | $0.01 | $0.01 |
| Louisiana | $0.01 | $0.01 |
| Texas | $0.01 | $0.01 |
What the Data Says About Injection, Tixagevimab And Cilgavimab, For The Pre-Exposure Prophylaxis Only, For Certain Adults And Pediatric Individuals (12 Years Of Age And Older Weighing At Least 40kg) With No Known Sars-Cov-2 Exposure, Who Either Have Moderate To Severely Compromise
Across 4 states with reporting providers, CPT code Q0220 (Injection, Tixagevimab And Cilgavimab, For The Pre-Exposure Prophylaxis Only, For Certain Adults And Pediatric Individuals (12 Years Of Age And Older Weighing At Least 40kg) With No Known Sars-Cov-2 Exposure, Who Either Have Moderate To Severely Compromise) shows a national average Medicare payment of $0.01 against an average billed charge of $5.10. That gap, a 510.0x markup, or 50900% above the Medicare allowed amount, is not a meaningful ratio for this low-payment code, so treat the billed figure as a chargemaster reference point rather than a real-world price.
Temporary Codes procedures like this one saw 101 services billed to Medicare in 2023 by 48 distinct providers, serving 101 unique beneficiaries. State-level variation is significant: Texas reports the lowest average payment at $0.01, while California reports the highest at $0.01. At just 0%, this procedure prices remarkably consistently nationwide, GPCI adjustments barely move the needle for this particular code.
Applying RAND 2024 commercial-to-Medicare ratios specific to the Temporary Codes category (2.24x), the estimated commercial insurance price lands near $0.02, with self-pay cash discounts commonly bringing the figure closer to $1.41. Within Temporary Codes, Injection, Tixagevimab And Cilgavimab, For The Pre-Exposure Prophylaxis Only, For Certain Adults And Pediatric Individuals (12 Years Of Age And Older Weighing At Least 40kg) With No Known Sars-Cov-2 Exposure, Who Either Have Moderate To Severely Compromise ranks #179 of 180 tracked procedures by national average Medicare payment.
What to do with this
If you may have injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromise done, these steps turn the numbers above into a real-world cost estimate.
- Request a Good Faith Estimate from your provider at least 3 business days before a scheduled procedure, under the No Surprises Act it is an enforceable written price.
- Compare injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromise costs in your state, Medicare rates vary by locality. Browse states
- Check a hospital’s published cash price, which is often far below the billed charge. Price transparency
- Understand why billed charges run several times the Medicare rate before you negotiate. Read the guide
Figures here are averages and estimates, not a quote. Confirm coverage and out-of-pocket costs with your insurer and provider.
Frequently Asked Questions
How much does Injection, Tixagevimab And Cilgavimab, For The Pre-Exposure Prophylaxis Only, For Certain Adults And Pediatric Individuals (12 Years Of Age And Older Weighing At Least 40kg) With No Known Sars-Cov-2 Exposure, Who Either Have Moderate To Severely Compromise cost?
Injection, Tixagevimab And Cilgavimab, For The Pre-Exposure Prophylaxis Only, For Certain Adults And Pediatric Individuals (12 Years Of Age And Older Weighing At Least 40kg) With No Known Sars-Cov-2 Exposure, Who Either Have Moderate To Severely Compromise (CPT Q0220) is priced fairly consistently nationwide: Medicare pays $0.01 on average, and the $0.01-$0.01 state range stays relatively tight. Providers typically bill $5.10.
Why do providers charge more than Medicare pays?
Providers set their own chargemaster rates (billed charges), which are typically much higher than what any insurer pays. Medicare pays a fixed rate based on the procedure code and geographic location. The billed charge is relevant mainly for uninsured patients, who may face prices closer to the submitted charge.
How much does Injection, Tixagevimab And Cilgavimab, For The Pre-Exposure Prophylaxis Only, For Certain Adults And Pediatric Individuals (12 Years Of Age And Older Weighing At Least 40kg) With No Known Sars-Cov-2 Exposure, Who Either Have Moderate To Severely Compromise cost with insurance?
With commercial insurance, injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromise costs an estimated $0.02 on average (range: $0.02-$0.03), a moderate premium over Medicare's $0.01. Without insurance, the estimated cash price is $1.41.
Which state has the lowest cost for Injection, Tixagevimab And Cilgavimab, For The Pre-Exposure Prophylaxis Only, For Certain Adults And Pediatric Individuals (12 Years Of Age And Older Weighing At Least 40kg) With No Known Sars-Cov-2 Exposure, Who Either Have Moderate To Severely Compromise?
Texas and California bookend the range for Injection, Tixagevimab And Cilgavimab, For The Pre-Exposure Prophylaxis Only, For Certain Adults And Pediatric Individuals (12 Years Of Age And Older Weighing At Least 40kg) With No Known Sars-Cov-2 Exposure, Who Either Have Moderate To Severely Compromise, at $0.01 and $0.01 respectively - a relatively tight $0.00 spread nationwide.
How many providers perform Injection, Tixagevimab And Cilgavimab, For The Pre-Exposure Prophylaxis Only, For Certain Adults And Pediatric Individuals (12 Years Of Age And Older Weighing At Least 40kg) With No Known Sars-Cov-2 Exposure, Who Either Have Moderate To Severely Compromise?
Injection, Tixagevimab And Cilgavimab, For The Pre-Exposure Prophylaxis Only, For Certain Adults And Pediatric Individuals (12 Years Of Age And Older Weighing At Least 40kg) With No Known Sars-Cov-2 Exposure, Who Either Have Moderate To Severely Compromise is comparatively uncommon: only 48 providers nationally billed Medicare for it in 2023, serving 101 beneficiaries via 101 total services.
What is the billed-to-Medicare markup for Injection, Tixagevimab And Cilgavimab, For The Pre-Exposure Prophylaxis Only, For Certain Adults And Pediatric Individuals (12 Years Of Age And Older Weighing At Least 40kg) With No Known Sars-Cov-2 Exposure, Who Either Have Moderate To Severely Compromise?
Providers bill 510.0x what Medicare pays for Injection, Tixagevimab And Cilgavimab, For The Pre-Exposure Prophylaxis Only, For Certain Adults And Pediatric Individuals (12 Years Of Age And Older Weighing At Least 40kg) With No Known Sars-Cov-2 Exposure, Who Either Have Moderate To Severely Compromise - a markup within the typical range at 50900% above the Medicare rate.
Related Guides
Tips to reduce out-of-pocket costs
Your right to upfront pricing
How Medicare payments work
Decode charges and codes
Why bills exceed actual costs
Geographic pricing factors
Data from CMS Medicare Physician & Other Practitioners (2023).
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainProcedure is rendered directly from CMS Medicare Physician & Other Practitioners data, no number is typed in by an editor. This page draws directly on CMS Medicare Physician & Other Practitioners data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.